ReShape Lifesciences Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: ReShape Lifesciences Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
ReShape Lifesciences Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.76M, a 54.6% increase year-over-year.
ReShape Lifesciences Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$7.92M, a 73.8% increase year-over-year.
ReShape Lifesciences Inc. annual Operating Income (Loss) for 2023 was -$15.4M, a 66.8% increase from 2022.
ReShape Lifesciences Inc. annual Operating Income (Loss) for 2022 was -$46.4M, a 19.9% increase from 2021.
ReShape Lifesciences Inc. annual Operating Income (Loss) for 2021 was -$57.9M, a 365% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$15.4M	+$31M	+66.8%	Jan 1, 2023	Dec 31, 2023	10-K	2024-04-01
2022	-$46.4M	+$11.5M	+19.9%	Jan 1, 2022	Dec 31, 2022	10-K	2024-04-01
2021	-$57.9M	-$45.4M	-365%	Jan 1, 2021	Dec 31, 2021	10-K	2023-04-17
2020	-$12.5M	+$10.8M	+46.4%	Jan 1, 2020	Dec 31, 2020	10-K	2022-04-08
2019	-$23.2M	+$13.7M	+37.2%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-12
2018	-$37M	-$2.57M	-7.49%	Jan 1, 2018	Dec 31, 2018	10-K	2020-02-27
2017	-$34.4M	-$14.9M	-76.3%	Jan 1, 2017	Dec 31, 2017	10-K	2019-02-22
2016	-$19.5M	-$4.57M	-30.6%	Jan 1, 2016	Dec 31, 2016	10-K	2018-03-05
2015	-$14.9M	-$5.09M	-51.8%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-05
2014	-$9.84M			Jan 1, 2014	Dec 31, 2014	10-K	2017-02-23

Showing 1 to 10 of 10 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.